AB&B BIO-TECH-B (02627) applies for full circulation of H shares.
Zhonghui Biotechnology-B (02627) announced that on October 15, 2025, the company has reached an agreement with the company's 816...
AB&B BIO-TECH-B (02627) announced that on October 15, 2025, the company has applied to the China Securities Regulatory Commission for the conversion of 81.662 million unlisted shares of the company into H shares and the listing of such shares on the Hong Kong Stock Exchange.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
